Aytu BioPharma, Inc. (AYTU) vs LeonaBio, Inc. (LONA)

A side-by-side comparison of Aytu BioPharma, Inc. and LeonaBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AYTU vs LONA

growth of $100 · dividends reinvested · last 6y
AYTU -99.2% (-55.1%/yr)LONA -96.7% (-43.5%/yr)LONA compounded faster over this window
050100150200Start $100202120222023202420252026$1$3
AYTU LONA

AYTU vs LONA: by the numbers

  • •LONA is the larger company ($23M vs $22M market cap).
  • •Both run net losses; LONA's is the smaller (0.00% vs -24.76% net margin).

Metrics side by side

Valuation

MetricAYTULONA
P/S ratio0.38N/A
P/B ratio0.620.67
FCF yield14.85%N/A

Profitability

MetricAYTULONA
Gross margin63.95%0.00%
Operating margin-14.44%0.00%
Net margin-24.76%0.00%
ROE-40.40%-421.06%
ROIC-14.21%-248.21%

Growth (annualized)

MetricAYTULONA
Revenue CAGR (5Y)-2.59%N/A
Total return CAGR (5Y)-48.14%-43.13%

Frequently asked

How have AYTU and LONA total returns compared?
Over the past 5 years, AYTU delivered -48.14% and LONA delivered -43.13% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.